FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hiroyuki Shimada

Research Profile

Disorders

Living Beings

Concepts & Ideas

Anatomy

Physiology

Chemicals & Drugs

Procedures

Neoplasm Transplantation

Co-author Network

Publications

TOP 3
Naohiko Ikegaki; Joshua R Jacobs; Eric F Rappaport; Paul L Regan; Hiroyuki Shimada; Autumn M Fox; Sakeenah L Hicks; Xao X Tang
Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas.
Yao-Te Hsieh; Sandra Huantes; Eun-Suk Kang; Jacob Andrade; Halvard Bönig; Doreen Chudziak; Gay M Crooks; Katrin Dauber; Eun Ji Gang; Huimin Geng; Nora Heisterkamp; Wolf-Karsten Hofmann; Lars Klemm; Hong Hoe Koo; Mignon Loh; Markus Müschen; Thalia Papayannopoulou; Reshmi Parameswaran; Eugene Park; Paul Schaefer; Carlton Scharman; Hiroyuki Shimada; Seyedmehdi Shojaee; Cheryl L Willman; Yong-Mi Kim
Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.
Rie Suganuma; Larry L Wang; Gabriele Amann; Klaus Beiske; Susan Cohn; Catherine J Cullinane; Emanuele S G d'Amore; Claudio Gambini; Julie M Gastier-Foster; Michael D Hogarty; JA Jarzembowski; Vijay V Joshi; Wendy B London; A Thomas Look; John M Maris; Arlene Naranjo; Samuel Navarro; Julie R Park; Michel Peuchmaur; Hideki Sano; Robert C Seeger; Hiroyuki Shimada
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hiroyuki Shimada (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Naohiko Ikegaki; Joshua R Jacobs; Eric F Rappaport; Paul L Regan; Hiroyuki Shimada; Autumn M Fox; Sakeenah L Hicks; Xao X Tang
Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(15):6097-102.
2013: Yao-Te Hsieh; Sandra Huantes; Eun-Suk Kang; Jacob Andrade; Halvard Bönig; Doreen Chudziak; Gay M Crooks; Katrin Dauber; Eun Ji Gang; Huimin Geng; Nora Heisterkamp; Wolf-Karsten Hofmann; Lars Klemm; Hong Hoe Koo; Mignon Loh; Markus Müschen; Thalia Papayannopoulou; Reshmi Parameswaran; Eugene Park; Paul Schaefer; Carlton Scharman; Hiroyuki Shimada; Seyedmehdi Shojaee; Cheryl L Willman; Yong-Mi Kim
Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.
Blood 2013;121(10):1814-8.
2013: Rie Suganuma; Larry L Wang; Gabriele Amann; Klaus Beiske; Susan Cohn; Catherine J Cullinane; Emanuele S G d'Amore; Claudio Gambini; Julie M Gastier-Foster; Michael D Hogarty; JA Jarzembowski; Vijay V Joshi; Wendy B London; A Thomas Look; John M Maris; Arlene Naranjo; Samuel Navarro; Julie R Park; Michel Peuchmaur; Hideki Sano; Robert C Seeger; Hiroyuki Shimada
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.
Pediatric blood & cancer 2013;60(3):363-70.
2013: Wanjing Ding; Qiaojun He; Lin Li; Rahul Mittal; Nemani V Prasadarao; Hiroyuki Shimada; Koichi Shudo; Xiaokun Zhang; Lingtao Wu
Retinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model.
Blood 2013;121(6):996-1007.
2012: Vijay V Joshi; Hiroyuki Shimada
Primary renal neuroblastoma.
The American journal of surgical pathology 2012;36(12):1904-5; author reply 1905.
2012: Shahab Asgharzadeh; Frank Berthold; Matthias Fischer; Michael Hadjidaniel; Lingyun Ji; Susan G Kreissman; Cathy Wei-Yao Liu; Wendy B London; Katherine K Matthay; Leonid S Metelitsa; André Oberthuer; Roger Pique-Regi; Jill A Salo; Hiroyuki Shimada; Richard Sposto; Judith G Villablanca; Peter Wakamatsu; Robert C Seeger
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(28):3525-32.
2012: Araz Marachelian; Katherine K Matthay; Hideki Sano; Hiroyuki Shimada; Richard Sposto; James Stein; David Baker; Hollie Jackson; Judith G Villablanca
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
Pediatric blood & cancer 2012;58(5):675-81.
2012: Tom B Davidson; Mark D Krieger; Ashok Panigrahy; Linda M Randolph; Pedro A Sanchez-Lara; Hiroyuki Shimada; Shi-Qi Wu; Anat Erdreich-Epstein
Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature.
BMC medical genetics 2012;13():19.
2011: Linda M Randolph; Hollie A Jackson; Jing Wang; Hiroyuki Shimada; Pedro A Sanchez-Lara; Derek A Wong; Lee-Jun C Wong; Richard G Boles
Fatal infantile lactic acidosis and a novel homozygous mutation in the SUCLG1 gene: a mitochondrial DNA depletion disorder.
Molecular genetics and metabolism 2011;102(2):149-52.
2011: Aaron Cooper; John van Doorninck; Lingyun Ji; Darren Russell; Marc Ladanyi; Hiroyuki Shimada; Mark Krailo; Richard B Womer; Jessie Hao-ru Hsu; Dafydd Thomas; Timothy Triche; Richard Sposto; Elizabeth Lawlor
Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(1):56-66.
2010: John A van Doorninck; Lingyun Ji; Betty Schaub; Hiroyuki Shimada; Michele R Wing; Mark Krailo; Stephen L Lessnick; Neyssa M Marina; Timothy Triche; Richard Sposto; Richard B Womer; Elizabeth Lawlor
Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(12):1989-94.
2009: Chizuko Okamatsu; Wendy B London; Arlene Naranjo; Michael D Hogarty; Julie M Gastier-Foster; A Thomas Look; Michael P LaQuaglia; John M Maris; Susan Cohn; Katherine K Matthay; Robert C Seeger; Tsutomu Saji; Hiroyuki Shimada
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
Pediatric blood & cancer 2009;53(4):563-9.
2009: Katherine K Matthay; Charles Patrick Reynolds; Robert C Seeger; Hiroyuki Shimada; E Stanton Adkins; Daphne A Haas-Kogan; Robert B Gerbing; Wendy B London; Judith G Villablanca
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(7):1007-13.
2009: Elai Davicioni; Michael Anderson; Friedrich Graf Finckenstein; James C Lynch; Stephen J Qualman; Hiroyuki Shimada; Deborah E Schofield; Jonathan D Buckley; William H Meyer; Poul H B Sorensen; Timothy Triche
Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.
The American journal of pathology 2009;174(2):550-64.
2009: Tasnim Ara; Liping Song; Hiroyuki Shimada; Nino Keshelava; Heidi V Russell; Leonid S Metelitsa; Susan G Groshen; Robert C Seeger; Yves A DeClerck
Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.
Cancer research 2009;69(1):329-37.
2008: Yue-Xin Ren; Friedrich Graf Finckenstein; Diana A Abdueva; Violette Shahbazian; Brile Chung; Kenneth I Weinberg; Timothy Triche; Hiroyuki Shimada; Michael Anderson
Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations.
Cancer research 2008;68(16):6587-97.
2008: Yasushi Fukaya; Hiroyuki Shimada; Ling-Chi Wang; Ebrahim Zandi; Yves A DeClerck
Identification of galectin-3-binding protein as a factor secreted by tumor cells that stimulates interleukin-6 expression in the bone marrow stroma.
The Journal of biological chemistry 2008;283(27):18573-81.
2007: Catherine J Hunter; Hiroyuki Shimada; Morris Asch
An unusual case of neuroblastoma with angiomatoid features.
Journal of pediatric surgery 2007;42(12):e11-3.
2007: Hideki Sano; Ignacio Gonzalez-Gomez; Shi-Qi Wu; Saro H Armenian; Rima F Jubran; Hiroyuki Shimada
A case of composite neuroblastoma composed of histologically and biologically distinct clones.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2007;10(3):229-32.
2007: Hyung-Gyoo Kang; Jasmine M Jenabi; Jingsong Zhang; Nino Keshelava; Hiroyuki Shimada; William A. May; Tony Ng; Charles Patrick Reynolds; Timothy Triche; Poul H B Sorensen
E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.
Cancer research 2007;67(7):3094-105.
2006: Shahab Asgharzadeh; Roger Pique-Regi; Richard Sposto; Hong Wang; Yujun Yang; Hiroyuki Shimada; Katherine K Matthay; Jonathan Buckley; Antonio Ortega; Robert C Seeger
Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification.
Journal of the National Cancer Institute 2006;98(17):1193-203.
2006: Hideki Sano; Jeffrey Bonadio; Robert B Gerbing; Wendy B London; Katherine K Matthay; John N Lukens; Hiroyuki Shimada
International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
European journal of cancer (Oxford, England : 1990) 2006;42(8):1113-9.
2005: Yasuyoshi Sohara; Hiroyuki Shimada; Yves A DeClerck
Mechanisms of bone invasion and metastasis in human neuroblastoma.
Cancer letters 2005;228(1-2):203-9.
2005: Mary Lou Schmidt; Ashutosh Lal; Robert C Seeger; John M Maris; Hiroyuki Shimada; Maura O'Leary; Robert B Gerbing; Katherine K Matthay
Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6474-80.
2005: Siwen Hu-Lieskovan; Jingsong Zhang; Lingtao Wu; Hiroyuki Shimada; Deborah E Schofield; Timothy Triche
EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
Cancer research 2005;65(11):4633-44.
2005: Anat Erdreich-Epstein; Linda B Tran; Orla T Cox; Elaine Y Huang; Walter E Laug; Hiroyuki Shimada; Melissa Millard
Endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 involves ceramide metabolic pathways.
Blood 2005;105(11):4353-61.
2005: Hiroshi Kobayashi; Denise A Carbonaro; Karen A Pepper; Denise Petersen; Shundi Ge; Holly Jackson; Hiroyuki Shimada; Rex Moats; Donald B Kohn
Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(5):776-89.
2005: Sonata Jodele; Christophe F Chantrain; Laurence Blavier; Carolyn Lutzko; Gay M Crooks; Hiroyuki Shimada; Lisa M Coussens; Yves A DeClerck
The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent.
Cancer research 2005;65(8):3200-8.
2005: Yasuyoshi Sohara; Hiroyuki Shimada; Cedric Minkin; Anat Erdreich-Epstein; Jan A Nolta; Yves A DeClerck
Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells.
Cancer research 2005;65(4):1129-35.
2005: Chie Kobayashi; Hector L Monforte-Munoz; Robert B Gerbing; Daniel O Stram; Katherine K Matthay; John N Lukens; Robert C Seeger; Hiroyuki Shimada
Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
Cancer 2005;103(1):174-80.
2004: Hiroyuki Shimada; Atsuko Nakagawa; Julius Peters; Hong Wang; Peter K Wakamatsu; John N Lukens; Katherine K Matthay; Stuart E Siegel; Robert C Seeger
TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Cancer 2004;101(8):1873-81.
2004: Angela Ferrario; Christophe F Chantrain; Karl Von Tiehl; Sue Buckley; Natalie Rucker; David R Shalinsky; Hiroyuki Shimada; Yves A DeClerck; Charles J Gomer
The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model.
Cancer research 2004;64(7):2328-32.
2004: Christophe F Chantrain; Hiroyuki Shimada; Sonata Jodele; Susan Groshen; Wei Ye; David R Shalinsky; Zena Werb; Lisa M Coussens; Yves A DeClerck
Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment.
Cancer research 2004;64(5):1675-86.
2004: Val T Hill; Stacy M Townsend; Robyn S Arias; Jasmine M Jenabi; Ignacio Gomez-Gonzalez; Hiroyuki Shimada; Julie L Badger
TraJ-dependent Escherichia coli K1 interactions with professional phagocytes are important for early systemic dissemination of infection in the neonatal rat.
Infection and immunity 2004;72(1):478-88.
2003: Michel Peuchmaur; Emanuele S G d'Amore; Vijay V Joshi; Jun-ichi Hata; Borghild Roald; Louis P Dehner; Robert B Gerbing; Daniel O Stram; John N Lukens; Katherine K Matthay; Hiroyuki Shimada
Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.
Cancer 2003;98(10):2274-81.
2003: Sunil K Sukumaran; Hiroyuki Shimada; Nemani V Prasadarao
Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A.
Infection and immunity 2003;71(10):5951-61.
2003: Stacy M Townsend; Harvey A Pollack; Ignacio Gonzalez-Gomez; Hiroyuki Shimada; Julie L Badger
Citrobacter koseri brain abscess in the neonatal rat: survival and replication within human and rat macrophages.
Infection and immunity 2003;71(10):5871-80.
2003: Yasuyoshi Sohara; Hiroyuki Shimada; Miriam Scadeng; Harvey Pollack; Shinya Yamada; Wei Ye; Charles Patrick Reynolds; Yves A DeClerck
Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate.
Cancer research 2003;63(12):3026-31.
2002: Leonid S Metelitsa; Stephen D Gillies; Michael Super; Hiroyuki Shimada; Charles Patrick Reynolds; Robert C Seeger
Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.
Blood 2002;99(11):4166-73.
2002: Takashi Taga; Atsushi Suzuki; Ignacio Gonzalez-Gomez; Floyd H Gilles; Monique F Stins; Hiroyuki Shimada; Lora Barsky; Kenneth I Weinberg; Walter E Laug
alpha v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin.
International journal of cancer. Journal international du cancer 2002;98(5):690-7.
2002: Inge M Ambros; Jun-ichi Hata; Vijay V Joshi; Borghild Roald; Louis P Dehner; Heinz Tüchler; Ulrike Pötschger; Hiroyuki Shimada
Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups.
Cancer 2002;94(5):1574-83.
2001: S Goto; S Umehara; Robert B Gerbing; Daniel O Stram; Garrett M Brodeur; Robert C Seeger; John N Lukens; Katherine K Matthay; Hiroyuki Shimada
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Cancer 2001;92(10):2699-708.
2001: Hiroyuki Shimada; S Umehara; Y Monobe; Y Hachitanda; Atsuko Nakagawa; S Goto; Robert B Gerbing; Daniel O Stram; John N Lukens; Katherine K Matthay
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Cancer 2001;92(9):2451-61.
2001: C Isogai; Walter E Laug; Hiroyuki Shimada; P J Declerck; Monique F Stins; Donald L Durden; Anat Erdreich-Epstein; Yves A DeClerck
Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin.
Cancer research 2001;61(14):5587-94.
2001: TJ MacDonald; T Taga; Hiroyuki Shimada; P Tabrizi; Berislav V Zlokovic; David A Cheresh; Walter E Laug
Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist.
Neurosurgery 2001;48(1):151-7.
2000: S Umehara; Atsuko Nakagawa; Katherine K Matthay; John N Lukens; Robert C Seeger; Daniel O Stram; Robert B Gerbing; Hiroyuki Shimada
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.
Cancer 2000;89(5):1150-61.
2000: Mary Lou Schmidt; John N Lukens; Robert C Seeger; Garrett M Brodeur; Hiroyuki Shimada; Robert B Gerbing; Daniel O Stram; C Perez; Gerald M Haase; Katherine K Matthay
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1260-8.
2000: Anat Erdreich-Epstein; Hiroyuki Shimada; Susan Groshen; M Liu; Leonid S Metelitsa; Kwang S Kim; Monique F Stins; Robert C Seeger; Donald L Durden
Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.
Cancer research 2000;60(3):712-21.
2000: C A Perez; Katherine K Matthay; JB Atkinson; Robert C Seeger; Hiroyuki Shimada; Gerald M Haase; Daniel O Stram; Robert B Gerbing; John N Lukens
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(1):18-26.
1999: Donald B Shaul; Hui-wen Xie; Hiroyuki Shimada; Brian E Hardy; Kathryn D Anderson
Venous ischemia as a cause of ureteral necrosis in transplanted ureters.
Journal of pediatric surgery 1999;34(11):1725-7.
1999: Katherine K Matthay; Judith G Villablanca; Robert C Seeger; Daniel O Stram; R E Harris; N K Ramsay; Patrick S Swift; Hiroyuki Shimada; CT Black; Garrett M Brodeur; Robert B Gerbing; Charles Patrick Reynolds
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
The New England journal of medicine 1999;341(16):1165-73.
1999: Hiroyuki Shimada; Inge M Ambros; Louis P Dehner; Jun-ichi Hata; Vijay V Joshi; Borghild Roald; Daniel O Stram; Robert B Gerbing; John N Lukens; Katherine K Matthay; Robert P Castleberry
The International Neuroblastoma Pathology Classification (the Shimada system).
Cancer 1999;86(2):364-72.
1999: Hiroyuki Shimada; Inge M Ambros; Louis P Dehner; Jun-ichi Hata; Vijay V Joshi; Borghild Roald
Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
Cancer 1999;86(2):349-63.
1999: S G DuBois; Y Kalika; John N Lukens; Garrett M Brodeur; Robert C Seeger; JB Atkinson; Gerald M Haase; CT Black; C Perez; Hiroyuki Shimada; Robert B Gerbing; Daniel O Stram; Katherine K Matthay
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.
Journal of pediatric hematology/oncology 1999;21(3):181-9.
1999: Y Sugiura; L Ma; B Sun; Hiroyuki Shimada; Walter E Laug; Robert C Seeger; Yves A DeClerck
The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis.
Cancer research 1999;59(6):1327-36.
1998: TJ MacDonald; P Tabrizi; Hiroyuki Shimada; Berislav V Zlokovic; Walter E Laug
Detection of brain tumor invasion and micrometastasis in vivo by expression of enhanced green fluorescent protein.
Neurosurgery 1998;43(6):1437-42; discussion 1442-3.
1998: Y Sugiura; Hiroyuki Shimada; Robert C Seeger; Walter E Laug; Yves A DeClerck
Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
Cancer research 1998;58(10):2209-16.
1998: Katherine K Matthay; C Perez; Robert C Seeger; Garrett M Brodeur; Hiroyuki Shimada; JB Atkinson; CT Black; Robert B Gerbing; Gerald M Haase; Daniel O Stram; Patrick S Swift; John N Lukens
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1256-64.
1996: S Imren; D B Kohn; Hiroyuki Shimada; Laurence Blavier; Yves A DeClerck
Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion.
Cancer research 1996;56(13):2891-5.
1994: Y A De Clerck; Hiroyuki Shimada; S M Taylor; KE Langley
Matrix metalloproteinases and their inhibitors in tumor progression.
Annals of the New York Academy of Sciences 1994;732():222-32.
1994: Y A De Clerck; Ofelia Alvarez; Hiroyuki Shimada; S M Taylor; KE Langley
Tissue inhibitors of metalloproteinases: role in tumor progression.
Contributions to nephrology 1994;107():108-15.
1994: Y A De Clerck; Hiroyuki Shimada; Ignacio Gonzalez-Gomez; Corey Raffel
Tumoral invasion in the central nervous system.
Journal of neuro-oncology 1994;18(2):111-21.
1993: Walter E Laug; X R Cao; Y B Yu; Hiroyuki Shimada; Egbert Kruithof
Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2.
Cancer research 1993;53(24):6051-7.
1993: S Ota; D C Crabbe; T N Tran; Timothy Triche; Hiroyuki Shimada
Malignant rhabdoid tumor. A study with two established cell lines.
Cancer 1993;71(9):2862-72.
1993: Hiroyuki Shimada
Tumors of the neuroblastoma group.
Pathology (Philadelphia, Pa.) 1993;2(1):43-59.
1992: A De Chiara; Jan M. Van Tornout; Y Hachitanda; J A Ortega; Hiroyuki Shimada
Melanotic neuroectodermal tumor of infancy. A case report of paratesticular primary with lymph node involvement.
The American journal of pediatric hematology/oncology 1992;14(4):356-60.
1992: Yves A DeClerck; N Perez; Hiroyuki Shimada; Tom Boone; KE Langley; S M Taylor
Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases.
Cancer research 1992;52(3):701-8.
1991: Yves A DeClerck; T D Yean; D Chan; Hiroyuki Shimada; KE Langley
Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor.
Cancer research 1991;51(8):2151-7.